TCL Archive In Brief: John Campbell, Nida Contracts Chief, New Head Of NCI Contracts Branch; PHS Honors Seven At NCI June 10, 1983
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies June 25, 2010
TCL Archive FDA Advisors Okay NCI Toxicology Proposals, Write New Clinical Guidelines, Approve AIN DA October 19, 1979
